RecruitingNot ApplicableNCT04939012

Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period


Sponsor

University of Pittsburgh

Enrollment

400 participants

Start Date

Oct 11, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria10

  • Prenatal Cohort:
  • Be greater than or equal to 18 years of age.
  • Be pregnant with an EGA of 22 to 37 weeks at enrollment.
  • Plan to deliver at research site.
  • Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.
  • Postpartum Cohort:
  • Be greater than or equal to 18 years of age.
  • Be 0-9 days postpartum at enrollment.
  • Have delivered at research site.
  • Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.

Exclusion Criteria4

  • Have had a fetal or neonatal death with their current pregnancy.
  • Be currently in jail or prison as required by court of law. Persons on probation or in residential facilities do not need to be excluded.
  • Have any other condition (social or medical) which, in the opinion of the Investigator, would make study participation unsafe, make study participation difficult, and/or complicate data interpretation.
  • PPC ONLY: Documented tubal ligation or hysterectomy procedures at time of delivery hospitalization

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMyPath Intervention

MyPath is a novel patient-centered, reproductive planning decision support tool developed by the research team used to facilitate postpartum contraceptive decision-making among women with SUDs. Designed to facilitate high-quality decisions regarding pregnancy and contraception, MyPath helps women a) review their thoughts about pregnancy and children, b) learn about fertility and preconception health and c) prioritize their preferences for various contraceptive method characteristics (e.g. effectiveness, side effects). As such, MyPath uses a patient-centered approach to help women frame their contraceptive decisions in the context of their goals and health and is a critical first step towards addressing reproductive health inequities among women with SUDs.

BEHAVIORALUsual care

Standard of Care


Locations(1)

Magee Womens Hospital of UPMC

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04939012


Related Trials